L. F. Barr

The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.

R. Casero, L. F. Barr, S. Campbell, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Transitions between lung cancer phenotypes--implications for tumor progression.

S. Baylin, B. Nelkin, M. Mabry, 1991, Cancer cells.

Factors associated with fatal hemoptysis in cancer patients.

T. Walsh, T. Walsh, L. F. Barr, 1988, Chest.

Cancer Cells-overexpressing Small Cell Lung myc Agar Cloning Ability of c-Softthe Altered Cell : Environmental Interactions and Enhanced 1 Integrin with β 3 α Association of the Decreased Expression of Updated Version

C. Dang, L. F. Barr, S. Campbell, 2006 .

Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.

C. Dang, L. F. Barr, S. Campbell, 1998, Cancer research.

Protein kinase C-beta 2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells.

S. Baylin, L. F. Barr, S. Campbell, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Cell-substratum interactions mediate oncogene-induced phenotype of lung cancer cells.

S. Baylin, D. Ball, M. Penno, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation.

S. Baylin, W. May, B. Nelkin, 1991, Cancer research.

N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery

K. Kolodner, L. F. Barr, 2008, Critical care medicine.

Postoperative Multimodal Analgesia in Cardiac Surgery.

M. Mazzeffi, L. F. Barr, B. Taylor, 2020, Critical care clinics.

c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.

E. Gabrielson, G. Diette, C. Dang, 2000, Cancer research.